Gujarat Kidney And Super Speciality (NSE:GKSL) Total Operating Expense: ₹529.2 Mil (TTM As of Mar. 2026)


NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
30 GF Score
Price ₹132.55
! 5 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality Total Operating Expense?

Gujarat Kidney And Super Speciality NSE:GKSL +1.20% 30 Total Operating Expense is ₹529.2 Mil as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 30/100. The stock has 5 warning signs investors should review.

Gujarat Kidney And Super Speciality's Total Operating Expense for the three months ended in Mar. 2026 was ₹224.2 Mil. Gujarat Kidney And Super Speciality's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹529.2 Mil.

Gujarat Kidney And Super Speciality Total Operating Expense Related Terms

Gujarat Kidney And Super Speciality Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Total Operating Expense Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Total Operating Expense
644.08 775.40 230.22 506.58

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial 70.42 65.00 158.73 146.28 224.18
NSE:GKSL
30GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹529.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹529.2 Mil mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Total Operating Expense of ₹529.2 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Gujarat Kidney And Super Speciality and its competitors.
Is Gujarat Kidney And Super Speciality's Total Operating Expense too high?
Gujarat Kidney And Super Speciality's current Total Operating Expense is ₹529.2 Mil. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Total Operating Expense compare to HCA and THC?
Gujarat Kidney And Super Speciality's Total Operating Expense of ₹529.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Gujarat Kidney And Super Speciality and its competitors. Gujarat Kidney And Super Speciality's current Total Operating Expense is ₹529.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Total Operating Expense of ₹529.2 Mil. The current Total Operating Expense is ₹529.2 Mil. Gujarat Kidney And Super Speciality's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Total Operating Expense is ₹529.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
30GF Score

Get the complete analysis for NSE:GKSL

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹132.55
Price